Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

BRD2 anticorps (AA 1-100)

BRD2 Reactivité: Humain WB, IHC Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN7265939
  • Antigène Voir toutes BRD2 Anticorps
    BRD2 (Bromodomain Containing 2 (BRD2))
    Épitope
    • 15
    • 7
    • 6
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-100
    Reactivité
    • 53
    • 6
    • 6
    • 5
    • 5
    • 4
    • 3
    • 3
    • 2
    • 1
    • 1
    Humain
    Hôte
    • 44
    • 8
    • 2
    Lapin
    Clonalité
    • 38
    • 16
    Polyclonal
    Conjugué
    • 28
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp BRD2 est non-conjugé
    Application
    • 28
    • 16
    • 14
    • 14
    • 12
    • 8
    • 6
    • 5
    • 4
    • 3
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC)
    Fonction
    BRD2 Rabbit pAb
    Séquence
    MASVPALQLT PANPPPPEVS NPKKPGRVTN QLQYLHKVVM KALWKHQFAW PFRQPVDAVK LGLPDYHKII KQPMDMGTIK RRLENNYYWA ASECMQDFNT
     Réactivité croisée
    Humain, Souris, Rat
    Attributs du produit
    Polyclonal Antibodies
    Purification
    Affinity purification
    Immunogène
    A synthetic peptide corresponding to a sequence within amino acids 1-100 of human BRD2 (NP_001186385.1).
    Isotype
    IgG
    Top Product
    Discover our top product BRD2 Anticorps primaire
  • Indications d'application
    WB,1:500 - 1:2000,IHC,1:50 - 1:200
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C
    Stockage commentaire
    Store at -20°C. Avoid freeze / thaw cycles.
  • Antigène
    BRD2 (Bromodomain Containing 2 (BRD2))
    Autre désignation
    BRD2 (BRD2 Produits)
    Synonymes
    anticorps D6S113E, anticorps FSH, anticorps FSRG1, anticorps NAT, anticorps RING3, anticorps RNF3, anticorps AW228947, anticorps D17H6S113E, anticorps Frg-1, anticorps Fsrg-1, anticorps Fsrg1, anticorps Nat, anticorps Ring3, anticorps Rnf3, anticorps mKIAA4005, anticorps brd2-a, anticorps fsh, anticorps fsrg1, anticorps nat, anticorps ring3, anticorps rnf3, anticorps brd2, anticorps fe47f02, anticorps fi85h05, anticorps wu:fe47f02, anticorps wu:fi85h05, anticorps Ring3 protein, anticorps bromodomain containing 2, anticorps bromodomain containing 2 S homeolog, anticorps bromodomain containing 2a, anticorps CHLREDRAFT_190116, anticorps CHLREDRAFT_150233, anticorps CHLREDRAFT_182576, anticorps CHLREDRAFT_188250, anticorps BRD2, anticorps Brd2, anticorps brd2.S, anticorps brd2a
    Sujet
    This gene encodes a transcriptional regulator that belongs to the BET (bromodomains and extra terminal domain) family of proteins. This protein associates with transcription complexes and with acetylated chromatin during mitosis, and it selectively binds to the acetylated lysine-12 residue of histone H4 via its two bromodomains. The gene maps to the major histocompatability complex (MHC) class II region on chromosome 6p21.3, but sequence comparison suggests that the protein is not involved in the immune response. This gene has been implicated in juvenile myoclonic epilepsy, a common form of epilepsy that becomes apparent in adolescence. Multiple alternatively spliced variants have been described for this gene.,BRD2,BRD2-IT1,D6S113E,FSH,FSRG1,NAT,O27.1.1,RING3,RNF3,Epigenetics & Nuclear Signaling,Signal Transduction,Kinase,Cell Biology & Developmental Biology,Ubiquitin,BRD2
    Poids moléculaire
    74kDa/83kDa/88kDa/92kDa
    ID gène
    6046
    UniProt
    P25440
    Pathways
    Chromatin Binding, SARS-CoV-2 Protein Interactome, Phosphorylation & l'infection par le SRAS-CoV-2
Vous êtes ici:
Support technique